Death From Irreversible Pulmonary Hypertension Associated With Short-term Use of Fenfluramine and Phentermine

JAMA: The Journal of the American Medical Association

Volumn 278, Issue 16, 1997, Pages 1320-

  Dillon, Kelley A ^a   Putnam, Kathleen G ^a   Avorn, Jerry L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANOREXIGENIC AGENT; FENFLURAMINE; PHENTERMINE;

ADULT; CASE REPORT; DEATH; FEMALE; HUMAN; LETTER; OBESITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; WEIGHT REDUCTION;

EID: 0030807425     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1997.03550160040035     Document Type: Letter

References (3)

1. Abenhaim L, Moride Y, Brenot F, et al. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609-616.
2. Ray WA, Griffin MR, Avorn J. Evaluating drugs after their approval for clinical use. N Engl J Med. 1993;329:2029-2032.
3. Connelly HM, Crary JL, McGoon MD, et al. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997;337:581-588.